₹397.95
₹-7.95 (-1.96%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹2,480 Cr
P/E
-277.29
ROE
-2.93%
ROCE
-2.42%
About Panacea Biotec Ltd
Panacea Biotec is one of India’s leading research-based biotechnology companies engaged in the business of research, development, manufacture and marketing of vaccines in India and international markets.
Founded
1984
CEO
Rajesh Jain
Employees
1,466
HQ
New Delhi, India
About Panacea Biotec Ltd
Panacea Biotec is one of India’s leading research-based biotechnology companies engaged in the business of research, development, manufacture and marketing of vaccines in India and international markets.
Founded:1984
CEO:Rajesh Jain
Employees:1,466
HQ:New Delhi, India
Finished Products
1Sale of Products
₹602.85Cr2Grant income from Government /
₹40.27Cr3Production Linked Incentive
₹16.50Cr4Other Operating Revenue
₹4.57Cr5Royalty income
₹2.06Cr6Sale of Services
₹1.87Cr7Export benefits
₹0.95Cr1–7 of 8
Raw Materials
1Cost of Materials Consumed
₹247.91Cr2Others-Purchase
₹1.75CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹647
52W Low
₹292
Volume81.92K
Avg VolumeN/A
Beta1.05
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-277.29x
Valuation
P/B Ratio
2.97x
Valuation
EPS
₹-1.46
Valuation
Dividend Yield
0.00%
Valuation
ROE
-2.93%
Profitability
ROCE
-2.42%
Profitability
Revenue by Segment
Contribution & growth by business line
Vaccines
-13.8%55.4%
₹309.84 Cr
Formulations
+24.9%44.6%
₹249.25 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
28.3%
International
71.7%
Overseas71.7%
Domestic28.3%
Strategic Relations
Collaborations, joint ventures & subsidiaries
N
National Institute of Immunology India
India
0.00% stakeN
National Institute of Health (NIH) USA
United States
0.00% stakeB
Biotech Consortium India Ltd
India
0.00% stakeD
Dr Reddy's Laboratories Ltd
—
0.00% stakeN
Netherland Vaccine Institute
Netherland
0.00% stakeN
National Research Development Corporation
India
0.00% stakeP
PT BioFarma
Indonesia
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.03x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
6.7%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.